DYN
Dyne Therapeutics, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders -9.1% ·
aandelenstroom -16.5% ·
netto nieuwe posities -10.0%
— formule
Brede distributie — dalende aandelen en minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q1 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 86 | +1 | 73.72M | $1.63B | +7 | −5 |
| Q1 2026 | 87 | -4 | 78.51M | $1.42B | +7 | −12 |
| Q4 2025 | 92 | 0 | 87.58M | $1.71B | +2 | −1 |
| Q3 2025 | 18 | +1 | 57.06M | $721.88M | +1 | −1 |
| Q2 2025 | 15 | +2 | 34.50M | $328.45M | +2 | — |
| Q1 2025 | 10 | -1 | 12.46M | $130.33M | +1 | −2 |
| Q4 2024 | 11 | 0 | 14.93M | $351.71M | +1 | −1 |
| Q3 2024 | 10 | -2 | 10.58M | $380.14M | +1 | −3 |
| Q2 2024 | 12 | — | 13.13M | $463.42M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passief) | 3.61M | -2.9% | $37.76M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | Citadel Advisors ✦ | 3.01M | +5.2% | $31.48M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 3 | Citadel Advisors ✦ | 3.01M | +5.2% | $31.48M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passief) | 1.96M | +3.6% | $20.46M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passief) | 1.96M | +3.6% | $20.46M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 1.82M | -24.2% | $19.04M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 7 | T. Rowe Price ✦ | 1.82M | -24.2% | $19.04M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 8 | Point72 Asset Management ✦ | 1.53M | +65.3% | $15.99M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | D. E. Shaw & Co. ✦ | 287.65K | +115.0% | $3.01M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | D. E. Shaw & Co. ✦ | 287.65K | +115.0% | $3.01M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 11 | Norges Bank ✦ (passief) | 109.92K | -88.4% | $1.15M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 12 | Millennium Management ✦ | 78.18K | +108.3% | $817,752 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Wellington Management ✦ | 36.32K | -5.8% | $379,929 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 14 | Wellington Management ✦ | 36.32K | -5.8% | $379,929 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 15 | Wellington Management ✦ | 36.32K | -5.8% | $379,929 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 16 | Wellington Management ✦ | 36.32K | -5.8% | $379,929 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 23.56K | Nieuw | $246,437 | 0.0% | New | 1 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 23.56K | Nieuw | $246,437 | 0.0% | New | 1 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 23.56K | Nieuw | $246,437 | 0.0% | New | 1 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 23.56K | Nieuw | $246,437 | 0.0% | New | 1 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 23.56K | Nieuw | $246,437 | 0.0% | New | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| AQR Capital Management | $246,437 | 0.0% |
| AQR Capital Management | $246,437 | 0.0% |
| AQR Capital Management | $246,437 | 0.0% |
| AQR Capital Management | $246,437 | 0.0% |
| AQR Capital Management | $246,437 | 0.0% |
Verlaten
| Adage Capital Partners | $45.94M | was 0.1% |
| Marshall Wace | $577,243 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 226 houders, 184.59M aandelen, $2.74B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Director · 1.36M aand · $33.99M
Director · 478.38K aand · $11.96M
Director · 322.46K aand · $8.06M
Director · 63.64K aand · $1.67M
Officer · 1.80K aand · $47,225
Officer · 1.56K aand · $40,892
Officer, Director · 4.99K aand · $131,032
Officer · 226 aand · $5,939
Director · 268.35K aand · $7.03M
Director · 94.42K aand · $2.47M
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie